WebApr 26, 2024 · Cytarabine may be used alone or in combination with other antineoplastic agents. It is indicated alone or in combination for induction of remission and/or maintenance in patients with acute myeloid leukaemia, acute non-lymphoblastic leukaemias, acute lymphoblastic leukaemias, acute lymphocytic leukaemia, erythroleukaemia, blast crises … WebMar 21, 2024 · DESCRIPTION. Cytarabine Injection, an antineoplastic, is a sterile solution of cytarabine for intravenous, intrathecal or subcutaneous administration.Each mL contains 100 mg cytarabine USP, in 2 g/20 mL (100 mg/mL) single dose vial and the following inactive ingredients: water for injection q.s. When necessary the pH is adjusted with …
CYTARABINE - Welcome to RobHolland.com
WebAug 1, 2024 · Cytarabine Injection, an antineoplastic agent, is a sterile preserved solution for intravenous or subcutaneous administration, and is available in a 500 mg (20 mg per mL) multi-dose vial. Each mL contains … WebJan 5, 2007 · The dose of 50 mg liposomal cytarabine was chosen based on review of prior phase 1 and 2 studies in adults (including patients aged 19 and older) and children. 9,12,13 The total number of IT treatments was chosen based on the fact that single-agent liposomal cytarabine would replace IT MTX (now eliminated) and standard cytarabine 100 mg . fixed intercept
Cytarabine - Drug Information - Chemocare
WebMay 16, 2024 · Collectively, these data indicated that CAF-derived exosome-induced chemoresistance to gemcitabine and cytarabine was at least in part due to the decreased expression of their transporter protein ... WebApr 6, 2024 · General: Only physicians experienced in cancer chemotherapy should use cytarabine. Warnings: Haematologic Effects: Cytarabine is a potent bone marrow suppressant; the severity depends on the dose of the drug and the schedule of administration.Therapy should be started cautiously in patients with pre-existing drug … WebSep 21, 2024 · Cytarabine syndrome reported; may manifest as fever, myalgia, bone pain, maculopapular rash, conjunctivitis, malaise, and occasionally chest pain. Generally occurs 6–12 hours after administration of conventional cytarabine. Corticosteroids are beneficial in treatment and prevention. can-med lines